112 related articles for article (PubMed ID: 12003779)
21. Cigarette smoke-induced CXCR3 receptor up-regulation mediates endothelial apoptosis.
Green LA; Petrusca D; Rajashekhar G; Gianaris T; Schweitzer KS; Wang L; Justice MJ; Petrache I; Clauss M
Am J Respir Cell Mol Biol; 2012 Dec; 47(6):807-14. PubMed ID: 22936405
[TBL] [Abstract][Full Text] [Related]
22. Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
Crippa L; Gasparri A; Sacchi A; Ferrero E; Curnis F; Corti A
Cancer Res; 2008 Feb; 68(4):1154-61. PubMed ID: 18281491
[TBL] [Abstract][Full Text] [Related]
23. EMAP II: a modulator of neovascularization in the developing lung.
Schwarz M; Lee M; Zhang F; Zhao J; Jin Y; Smith S; Bhuva J; Stern D; Warburton D; Starnes V
Am J Physiol; 1999 Feb; 276(2):L365-75. PubMed ID: 9950900
[TBL] [Abstract][Full Text] [Related]
24. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
[TBL] [Abstract][Full Text] [Related]
25. Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH.
Chang SY; Ko HJ; Heo TH; Kang CY
Mol Pharmacol; 2005 May; 67(5):1534-43. PubMed ID: 15710745
[TBL] [Abstract][Full Text] [Related]
26. EMAP-II facilitates TNF-R1 apoptotic signalling in endothelial cells and induces TRADD mobilization.
van Horssen R; Rens JA; Schipper D; Eggermont AM; ten Hagen TL
Apoptosis; 2006 Dec; 11(12):2137-45. PubMed ID: 17051333
[TBL] [Abstract][Full Text] [Related]
27. Endothelial monocyte-activating polypeptide II causes NOS-dependent pulmonary artery vasodilation: a novel effect for a proinflammatory cytokine.
Tsai BM; Wang M; Clauss M; Sun P; Meldrum DR
Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R767-71. PubMed ID: 15155281
[TBL] [Abstract][Full Text] [Related]
28. Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.
Kayton ML; Libutti SK
Curr Opin Investig Drugs; 2001 Jan; 2(1):136-8. PubMed ID: 11527006
[TBL] [Abstract][Full Text] [Related]
29. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
[TBL] [Abstract][Full Text] [Related]
30. Epithelial-mesenchymal interactions are linked to neovascularization.
Schwarz MA; Wan Z; Liu J; Lee MK
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):784-92. PubMed ID: 14672913
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effect of endothelial monocyte-activating polypeptide-II on human prostate adenocarcinoma in mouse xenograft model.
Reznikov AG; Chaykovskaya LV; Polyakova LI; Kornelyuk AI
Exp Oncol; 2007 Dec; 29(4):267-71. PubMed ID: 18199981
[TBL] [Abstract][Full Text] [Related]
32. Endothelial monocyte activating polypeptide II inhibits lung neovascularization and airway epithelial morphogenesis.
Schwarz MA; Zhang F; Gebb S; Starnes V; Warburton D
Mech Dev; 2000 Jul; 95(1-2):123-32. PubMed ID: 10906456
[TBL] [Abstract][Full Text] [Related]
33. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ΞΆ/PP2A-dependent signaling mechanism.
Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
[TBL] [Abstract][Full Text] [Related]
34. A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response.
Kao J; Fan YG; Haehnel I; Brett J; Greenberg S; Clauss M; Kayton M; Houck K; Kisiel W; Seljelid R
J Biol Chem; 1994 Apr; 269(13):9774-82. PubMed ID: 7545917
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II.
Kao J; Houck K; Fan Y; Haehnel I; Libutti SK; Kayton ML; Grikscheit T; Chabot J; Nowygrod R; Greenberg S
J Biol Chem; 1994 Oct; 269(40):25106-19. PubMed ID: 7929199
[TBL] [Abstract][Full Text] [Related]
36. Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide II.
Schwarz MA; Thornton J; Xu H; Awasthi N; Schwarz RE
PLoS One; 2012; 7(3):e33101. PubMed ID: 22412987
[TBL] [Abstract][Full Text] [Related]
37. EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest.
Yu Q; Liu L; Wang P; Yao Y; Xue Y; Liu Y
Cell Cycle; 2017 Jun; 16(11):1085-1092. PubMed ID: 28436750
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor-I reduces stress-induced gastric mucosal injury by inhibiting neutrophil activation in mice.
Zhao J; Harada N; Sobue K; Katsuya H; Okajima K
Growth Horm IGF Res; 2009 Apr; 19(2):136-45. PubMed ID: 18809348
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependent biphasic activity of tRNA synthetase-associating factor, p43, in angiogenesis.
Park SG; Kang YS; Ahn YH; Lee SH; Kim KR; Kim KW; Koh GY; Ko YG; Kim S
J Biol Chem; 2002 Nov; 277(47):45243-8. PubMed ID: 12237313
[TBL] [Abstract][Full Text] [Related]
40. Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis.
Berger AC; Tang G; Alexander HR; Libutti SK
J Immunother; 2000; 23(5):519-27. PubMed ID: 11001545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]